Ngā hua rapu - Jan Gerstoft

Whakamahine hua
  1. 1
    Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy?

    Can chemoprophylaxis against opportunistic infections be discontinued after an increase in CD4 cells induced by highly active antiretroviral therapy? mā Ole Kirk, Jens Lundgren, Court Pedersen, Henrik Nielsen, Jan Gerstoft

    I whakaputaina 1999
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Improved survival in HIV-infected persons: consequences and perspectives

    Improved survival in HIV-infected persons: consequences and perspectives mā Nicolai Lohse, Ann‐Brit Eg Hansen, Jan Gerstoft, Niels Obel

    I whakaputaina 2007
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    Incomplete Immune Recovery in HIV Infection: Mechanisms, Relevance for Clinical Care, and Possible Solutions

    Incomplete Immune Recovery in HIV Infection: Mechanisms, Relevance for Clinical Care, and Possible Solutions mā Julie C. Gaardbo, Hans Jakob Hartling, Jan Gerstoft, Susanne Dam Nielsen

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Syphilis and Human Immunodeficiency Virus (HIV)-1 Coinfection: Influence on CD4 T-Cell Count, HIV-1 Viral Load, and Treatment Response

    Syphilis and Human Immunodeficiency Virus (HIV)-1 Coinfection: Influence on CD4 T-Cell Count, HIV-1 Viral Load, and Treatment Response mā Klaus F. Kofoed, Jan Gerstoft, Peter M. H. Heegaard, Thomas Benfield

    I whakaputaina 2006
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Thirty Years with HIV Infection—Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors

    Thirty Years with HIV Infection—Nonprogression Is Still Puzzling: Lessons to Be Learned from Controllers and Long-Term Nonprogressors mā Julie C. Gaardbo, Hans Jakob Hartling, Jan Gerstoft, Susanne Dam Nielsen

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    Testing the hypothesis that treatment can eliminate HIV: a nationwide, population-based study of the Danish HIV epidemic in men who have sex with men

    Testing the hypothesis that treatment can eliminate HIV: a nationwide, population-based study of the Danish HIV epidemic in men who have sex with men mā Justin T Okano, Danielle Robbins, Laurence Palk, Jan Gerstoft, Niels Obel, Sally Blower

    I whakaputaina 2016
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Persistent Inflammation and Endothelial Activation in HIV-1 Infected Patients after 12 Years of Antiretroviral Therapy

    Persistent Inflammation and Endothelial Activation in HIV-1 Infected Patients after 12 Years of Antiretroviral Therapy mā Frederikke F. Rönsholt, Henrik Ullum, Terese L. Katzenstein, Jan Gerstoft, Sisse Rye Ostrowski

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Course and Clinical Significance of CD8<sup>+</sup>T-Cell Counts in a Large Cohort of HIV-Infected Individuals

    Course and Clinical Significance of CD8<sup>+</sup>T-Cell Counts in a Large Cohort of HIV-Infected Individuals mā Marie Helleberg, Gitte Kronborg, Henrik Ullum, Lars P. Ryder, Niels Obel, Jan Gerstoft

    I whakaputaina 2014
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Risk of Diabetes Mellitus in Persons with and without HIV: A Danish Nationwide Population-Based Cohort Study

    Risk of Diabetes Mellitus in Persons with and without HIV: A Danish Nationwide Population-Based Cohort Study mā Line Dahlerup Rasmussen, Elisabeth R. Mathiesen, Gitte Kronborg, Court Pedersen, Jan Gerstoft, Niels Obel

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Statin Therapy and Mortality in HIV-Infected Individuals; A Danish Nationwide Population-Based Cohort Study

    Statin Therapy and Mortality in HIV-Infected Individuals; A Danish Nationwide Population-Based Cohort Study mā Line Dahlerup Rasmussen, Gitte Kronborg, Carsten Schade Larsen, Court Pedersen, Jan Gerstoft, Niels Obel

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection.

    Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection. mā C. Pedersen, C. M. Nielsen, Bent Faber Vestergaard, Jan Gerstoft, Kim Krogsgaard, Jens Nielsen

    I whakaputaina 1987
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    CD4 Decline Is Associated With Increased Risk of Cardiovascular Disease, Cancer, and Death in Virally Suppressed Patients With HIV

    CD4 Decline Is Associated With Increased Risk of Cardiovascular Disease, Cancer, and Death in Virally Suppressed Patients With HIV mā Marie Helleberg, Gitte Kronborg, Carsten Schade Larsen, Gitte Pedersen, Court Pedersen, Niels Obel, Jan Gerstoft

    I whakaputaina 2013
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    Risk of cerebrovascular events in persons with and without HIV

    Risk of cerebrovascular events in persons with and without HIV mā Line Dahlerup Rasmussen, Frederik Neess Engsig, Hanne Christensen, Jan Gerstoft, Gitte Kronborg, Court Pedersen, Niels Obel

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial

    Combination therapy containing ritonavir plus saquinavir has superior short-term antiretroviral efficacy: a randomized trial mā Ole Kirk, Terese L. Katzenstein, Jan Gerstoft, Peter M. H. Heegaard, Henrik Nielsen, Court Pedersen, Jens Lundgren

    I whakaputaina 1999
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Incidence of low and high-energy fractures in persons with and without HIV infection

    Incidence of low and high-energy fractures in persons with and without HIV infection mā Ann‐Brit Eg Hansen, Jan Gerstoft, Gitte Kronborg, Carsten Schade Larsen, Court Pedersen, Gitte Pedersen, Niels Obel

    I whakaputaina 2011
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection

    The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection mā Alessandro Cozzi‐Lepri, Terese L. Katzenstein, Henrik Ullum, Andrew Phillips, Peter Skinhøj, Jan Gerstoft, Bente Klarlund Pedersen

    I whakaputaina 1998
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    A Highly Selective Cc Chemokine Receptor (Ccr)8 Antagonist Encoded by the Poxvirus Molluscum Contagiosum

    A Highly Selective Cc Chemokine Receptor (Ccr)8 Antagonist Encoded by the Poxvirus Molluscum Contagiosum mā Hans Rudolf Lüttichau, Johnny T. Stine, Thomas Boesen, Anders H. Johnsen, David Chantry, Jan Gerstoft, Thue W. Schwartz

    I whakaputaina 2000
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers

    The influence of HTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers mā Kim Krogsgaard, Bjarne Ørskov Lindhardt, Jens Ole Nielsen, Poul Andersson, Peter Kryger, Jan Aldershvile, Jan Gerstoft, Court Pedersen

    I whakaputaina 1987
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Impact of Non-HIV and HIV Risk Factors on Survival in HIV-Infected Patients on HAART: A Population-Based Nationwide Cohort Study

    Impact of Non-HIV and HIV Risk Factors on Survival in HIV-Infected Patients on HAART: A Population-Based Nationwide Cohort Study mā Niels Obel, Lars Haukali Omland, Gitte Kronborg, Carsten Schade Larsen, Court Pedersen, Gitte Pedersen, Henrik Toft Sørensen, Jan Gerstoft

    I whakaputaina 2011
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine

    Low efficacy and high frequency of adverse events in a randomized trial of the triple nucleoside regimen abacavir, stavudine and didanosine mā Jan Gerstoft, Ole Kirk, Niels Obel, Court Pedersen, Peter M. H. Heegaard, Henrik Nielsen, Terese L. Katzenstein, Jens Lundgren

    I whakaputaina 2003
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: